glp-1 agonist anxiety side effects Your guide to GLP-1 is both anxiogenic and

Curr Obes Rep

[DOI] [PMC free article] [PubMed] [Google Scholar] 82.Simonsen E., Lund L.C., Ernst M.T., et al

and China, focusing on efficacy and safety in larger populations, and only one clinical trial in phase II, indicating that they are either testing effectiveness on a larger scale or assessing long-term effects post-market release

Read The Times Of India article to understand how weight-loss therapies, GLP-1 medicines and digital health are shaping the next phase of pharma growth in India: To know about our healthcare industry solutions and strategic focus, visit: Rupali Mukherjee #Pharmaceuticals #HealthcareIndustry #DigitalHealth #LifeSciences #HealthcareInnovation To view or add a comment, sign in 2026: India's Obesity Drug Revolution is HERE

Am J Obstet Gynecol 198(6):611619 Lee KK, Raja EA, Lee AJ, Bhattacharya S, Norman JE, Reynolds RM (2015) Maternal obesity during pregnancy associates with premature mortality and major cardiovascular events in later life